Objective: The study was set up to determine to what extent the addition of a supplement of vitamin A alone or in combination with zinc would improve standard iron treatment and correction of iron de®ciency anaemia. Design: 216 non-pregnant anaemic women of 15 ± 45 years of age with haemoglobin levels 100 gal were randomly assigned to three treatment groups. One group (A) received iron alone, a second group (B) received iron and vitamin A, and a third group (C) received iron, vitamin A and zinc. Every woman was given one iron capsule per day for 60 days as FeSO 4 containing 60 mg of elemental iron. In addition, groups B and C received 200 000 IU of vitamin A, given as a supervised dose, on the ®rst day of the treatment after collection of the blood sample. Group C received one zinc tablet per day for 60 days as zinc gluconate containing 15 mg of elemental zinc. Setting: The north-western part of Bangladesh in the urban slums of Dinajpur district between February and August 1995. Subjects: To select women with a haemoglobin level of 100 gal, all the women of four randomly selected municipal slums of the district in the targeted age group (328) were invited to take part in the study. Blood samples were analysed for haemoglobin, serum iron, total iron binding capacity (TIBC), ferritin, retinol and zinc. Results: Out of the 328 women screened, 254 (77.5%) had a haemoglobin level 100 gal and 322 (98%) 120 gal. The three treatment schedules signi®cantly increased haemoglobin levels and improved iron parameters, except for serum iron in the group who received iron alone. The group who received iron, vitamin A and zinc responded best with an increase in haemoglobin of 17.9 gal as compared to the group receiving iron alone (13.4 gal). Iron and vitamin A treatment gave an intermediate response of 15.9 gal. However, these differences are only statistically signi®cant only for the group who received iron, vitamin A and zinc and only for the increase in haemoglobin, P 0.03.
Introduction
Iron de®ciency, and in particular iron de®ciency anaemia, remains a nutritional disorder of major importance. So much so that the Montreal meeting on micronutrients of October 1991 and the international conference on nutrition held in Rome in 1992, called for more efforts to control vitamin A de®ciency and reduce iron de®ciency before the end of the decade. It is estimated that more than 2 billion people suffer from iron de®ciency. Women in particular are affected and, although the prevalence¯uctuates widely between countries, it is estimated that 40 ± 50% of adult women in developing countries suffer from iron de®ciency anaemia (WHOaFAO, 1992) .
Notwithstanding the fact that the diagnosis of anaemia is fairly simple and the treatment cheap, the prevalence of anaemia remains high. This is due to a combination of factors such as poor compliance, the long duration of the treatment, side-effects and, in certain cases, insuf®cient health system coverage (ACCaSCN1991). The correction of the de®ciency can also be hampered by the effect of concomitant nutrient de®ciencies (West, 1996) .
Strong correlations between vitamin A status and haemoglobin levels have been demonstrated (Suharno et al, 1993) . Iron de®ciency is more easily corrected when there is no vitamin A de®ciency (Hodges et al, 1978; Mejia & Chew, 1998; Suharno et al, 1993) . Prolonged vitamin A de®ciency in animals negatively affects haematopoiesis, with a gradual replacement of the bone marrow by ®brous tissue (Hodges et al, 1978) . A depression of iron uptake by the bone marrow (Beyen et al, 1992; Sijtsma et al, 1993) was postulated to be one of the mechanisms in these studies. A food forti®cation trial in Guatemala with vitamin A and a supplementation study with vitamin A alone in Indonesia reported a bene®cial effect on haematopoiesis and haemoglobin status (Mejia & Arroyave, 1982; Bloem et al, 1990) . Haemoglobin levels increased through mobilisation of iron stores.
Zinc also interacts with vitamin A. Zinc de®ciency decreases levels of serum albumin, pre-albumin and transferrin. Pre-albumin levels increase rapidly with a zinc supplementation of 10 ± 15 days in zinc-de®cient subjects (Bates & McClain, 1981) . This effect is probably mediated through the effect of zinc on protein synthesis, most noticeable in the effect of zinc de®ciency on the synthesis of retinol binding protein (Smith et al, 1973) . Zinc was found to be necessary for normal mobilisation of vitamin A from the liver and for maintaining normal serum levels. A study from India among malnourished children supports this concept. The children showed a signi®cant increase of plasma vitamin A and retinol-binding protein in response to zinc supplementation (Shingwekar et al, 1979) . In a study performed in Thailand, no effect on retinol binding protein or serum retinol was noted when zinc was added to the vitamin A supplementation as compared to a group of children who received vitamin A alone (Udomkesmalee et al, 1992) . In this last study, however, it is not clear whether the children were signi®cantly zinc de®cient or to what degree. It can therefore be proposed that zinc, through its effect on retinol mobilisation, can affect utilisation of iron stores and so affect iron de®ciency anaemia.
Considering that iron de®ciency anaemia is a major problem and that the treatment is often unsuccessful, the present study was set up to determine to what extent the addition of a supplement of vitamin A alone or in combination with zinc would improve standard iron treatment and correction of iron de®ciency anaemia.
The study took place in Bangladesh where iron de®-ciency anaemia is very prevalent and where both vitamin A and zinc de®ciency have been documented (Simmer et al, 1990; Zeitlin et al, 1992; Baqui et al, 1994) .
Subjects and Methods
Non-pregnant women (n 328) between 15 and 45 years of age were screened for anaemia. The ®rst 216 women with a haemoglobin level 100 gal were randomly assigned to three treatment groups. One group received iron alone (A; n 72), a second group received iron and vitamin A (B; n 72) and a third group received iron, vitamin A and zinc (C; n 72). It was not considered ethical to include a placebo group as control. To perform randomisation, numbers from 1 to 216 were drawn out of a bag and allocated alternately to treatment groups to end up with groups of equal size. The sample size was calculated to demonstrate a difference of 5 gal haemoglobin between two groups with an alpha error of 5% and a beta error of 10%. The standard deviation was estimated from the literature as being 10 gal. The calculated sample size was in¯ated to allow 30% defaulters. Blood samples were taken at the start of the study, and at the end of 60 days treatment. The study was conducted in the north-western part of Bangladesh in the urban slums of Dinajpur district between February and August 1995.
Screening
To select women with a haemoglobin level of 100 gal, all the women of four randomly selected municipal slums areas of the district in the targeted age group (328) were invited to take part in the study. Blood was collected by ®nger prick for haemoglobin estimation by the cyanomethaemoglobin method with 2 ± 4 h (Lynch et al, 1969) . Every woman with a haemoglobin value below 100 gal was examined further. Women were excluded from the study on the basis of the following criteria: suffering from acute or chronic diseases or in¯ammatory conditions; acute or chronic blood loss or diseases such as aplastic anaemia, thalassaemia or haemolytic anaemia; intake of a megadose of vitamin A within the last 3 months; presently under iron tablet supplementation; any drug consumption other than paracetamol andaor antihistamines for minor ailments; blood transfusion or blood donation within the last 4 months; and pregnancy.
Enrolment
Out of 328 women screened, the ®rst 216 meeting the criteria participated in the study. All the women were informed about the objectives and operational processes of the study in group meetings. Verbal consent was obtained individually and all transport costs were reimbursed. The date of last menstruation was obtained to ensure non-pregnancy, which was rechecked in the subsequent months of drug supplementation.
The ethical committee of the Institute of Tropical Medicine of Antwerp approved the study.
Anthropometric measurements
Body weight (Wt) was measured with women wearing usual light clothing, to the nearest 0.1 kg, using an ordinary bathroom scale. Height (Ht) was measured to the nearest 0.1 cm by ®xing a measuring tape to the wall and having women stand barefoot on a concrete¯oor. Body Mass Index (BMI) is calculated as WtaHt 2 . Measurements of height were taken in duplicate by the same person, and the average was calculated.
Drug supplementation
Each woman was given one iron capsule per day for 60 days as FeSO 4 containing 60 mg of elemental iron (Bengal Tech Pharmaceuticals, Bangladesh). A plastic container was provided with 30 capsules during the blood sample collection sessions at the start and after one month. In addition, groups B and C received 200 000 IU of vitamin A (Hoffman-La Roche) given as a supervised dose, on the ®rst day of the treatment after collection of the blood sample. Group C received one zinc tablet per day for 60 days as zinc gluconate containing 15 mg of elemental zinc (Laboratory of Pharmaceutical Technology, University of Gent, Belgium). The tablets were packed in strips of 30 tablets and were given together with the iron tablet distribution. Instructions were given to take the zinc and iron tablets with separate meals. Drug compliance was supervised by twice-weekly household visits by two female slum health workers by asking whether the tablets had been taken the days before (iron and zinc where applicable). The activities of the health workers were also directly supervised by household visits by one of the authors.
Serum sample collection
Blood collections were carried out in a clinical laboratory on the ®rst day of treatment before the start of medication and at the end of 60 days of treatment. Women still anaemic at the end of the study continued to receive iron treatment for one more month. In each round, an average of 5 ml of venous blood was drawn by vacutainer syringes under cover of light protective aluminium foil, from which 20 ml was transferred immediately for the determination of blood haemoglobin levels by the cyanomethaemoglobin Vitamin Aazinc supplementation and anaemia P Kolsteren et al method. Serum was separated after centrifugations, from which 0.5 ml serum was transferred to an aluminium foilcovered test tube for determination of the retinol, which was then deep frozen below À20 C. To the rest of the serum, 3 ± 5 minute crystals of sodium azide were added and also frozen (À4 C to À12 C). These were used for all other determinations in the study. All the plastic test tubes, tips, syringes and needles used were warranted (Sarsted Ltd, Germany) to contain minerals in such a negligible amount that they would not in¯uence the analysis. , and serum zinc by atomic absorption spectrophotometry.
Biochemical analysis
Iron indices were analysed in the clinical laboratory of the Institute of Tropical Medicine, Antwerp, Belgium. Retinol and zinc estimations were done in the laboratory of the biochemistry and nutrition department of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B).
Statistical analysis
Differences between biochemical parameters at the beginning and at the end within the treatment groups were tested by the Wilcoxon signed rank test given that we are dealing with an anaemic population and the distributions of the biochemical parameters are not Gaussian. The biological baseline data between the three groups were tested for the same reason with the Kruskal ± Wallis test. Where the parameters were normally distributed and more than two groups needed to be compared, one-way analysis of variance was used. Serum ferritin differences between beginning and end are calculated and tested after natural logarithmic transformation given their non-normal distribution. Comparisons between the group who received iron alone and the two others were made using the paired t-test.
Results
Out of the 328 women screened, 254 (77.5%) had a haemoglobin level 100 gal and 322 (98%) 120 gal. The turnout for screening was more than 90% of the target population.
Of the 216 women who participated in the trial 171 are included in the analysis. The defaulter rates are comparable in the three groups: A 22%, B 21%, C 20%. The reasons for exclusion were illness during the treatment period (n 9), pregnancy (n 2), haemolysis of blood sample (n 1), refusal to participate further in the study (n 13) and poor compliance, i.e. no treatment taken more than 10% of the time (n 20). Table 1 shows the composition of the three participating groups at the start of the treatment. The three groups were comparable in initial haemoglobin, serum retinol, zinc, serum ferritin, transferrin saturation, total iron binding capacity and serum iron. The mean age (standard deviation) was 28.8 years (7.2) for group A, 28.0 years (7.9) for group B and 28.3 years (7.7) for group C. The mean BMI (s.d.) for group A was 19.1 kgam 2 (2.6), for group B 19.3 kgam 2 (3.1), and for group C 18.9 kgam 2 (3.0). Comparison of the three groups by a one-way analysis of variance showed that they were not signi®cantly different (F probability for Age was 0.86 and for BMI was 0.75). The body mass index in all groups was rather low and overall 44.4% of the women had a BMI below 18.5 and are to be considered underweight (James et al, 1988) . The prevalence of thinness in all three groups is comparable; in group A it was 46%, in group B 37% and in group C 50% (w 2 2.15, P 0.43). The serum retinol values are well within the normal range, with only one value in the de®ciency range (below 0.35 mmolal) and 6% having low values (`0.70 mmolal) (Arroyave et al, 1989) . Wilcoxon signed rank test.
Vitamin Aazinc supplementation and anaemia P Kolsteren et al Serum ferritin levels were below 12 mgal for 23% of the women. Transferrin saturation was found to be abnormal (`16%) in 53% of the analyses and 63% had low serum iron levels (`11.6 mmolal) (Guyatt et al, 1992) .
The three treatment schedules signi®cantly increased haemoglobin levels and improved iron parameters, except for serum iron in the group who received iron alone (Table  2) . Retinol levels did not alter over the 8-week period even in the groups who received a supplement. Zinc values are within normal range and again show no increase in the zinc-supplemented group. Whereas all women had Hb values below 100 gal at the beginning of the study, 74% had Hb values above 100 gal at the end. In 36% it had increased above 110 gal and only 9% were in the normal range. No difference in prevalence could be found between the three groups.
Discussion
Nutritional anaemia is a very serious problem worldwide, particularly for women in developing countries. In the slums of Dinajpur the present study documented a surprisingly high prevalence of anaemia, with 98% of the screened women having haemoglobin values below 120 gaL, and 77.5% below 100 gal.
Vitamin A de®ciency is a cause of nutritional anaemia (Shingwekar et al, 1979) . Hodges found in 1971 that volunteers on a prolonged vitamin A-de®cient diet anaemia that responded to vitamin A but not to iron (Hodges & Kolerd, 1971) . Subsequent studies demonstrated correlations between serum vitamin A and haemoglobin (Meija et al, 1977; Suharno et al, 1992) . Vitamin A forti®cation of sugar of Guatemala (Meija & Arroyave, 1982) and monosodium glutamate in Indonesia (Muhilal et al, 1988 ) also improved haemoglobin status in adults and children. Daily vitamin A supplements given either to children or to pregnant women signi®cantly increased haemoglobin levels in the observed populations.
The present study demonstrated the bene®cial effect of adding vitamin A and zinc to iron treatment for anaemia. Vitamin A added to the iron treatment did not signi®cantly increase the response in terms of haemoglobin increase, although an increase could be seen. There are several confounding factors that could have in¯uenced the results. A multitude of factors, nutritional and others, cause anaemia. Iron de®ciency is only one of them. The Dinajpur area is malaria free (Dr S Rahman personal communication), however. To identify iron de®ciency, biochemical parameters are accepted as useful indicators, but these indicators separately identify different population groups (Hastka et al, 1996) owing to their different sensitivity and speci®city. Punnonen and coworkers (Punnonen et al, 1997) estimated that in anaemic patients a cutoff limit of 41 mgal for ferritin provides the optimal diagnostic ef®ciency for iron de®ciency. In our population, 77% of the women can be considered iron de®cient on the basis of that criterion.
Vitamin A de®ciency does not appear to be a very serious problem in the studied populations, with 6% of the women having low serum retinol values. The expected bene®t of a vitamin A supplement could therefore have been less than in a more de®cient population. This also explains the observation that retinol values did not change. In mild de®ciency states, the supplements are mobilised to replenish the reserves with little change in serum retinol values (McLaren & Frigg, 1997) .
The studies that found an effect of a vitamin A supplement on haemoglobin values gave supplements on a daily basis, whereas in the present study only one megadose was administered. Single massive doses were indeed found to be less effective in improving haemoglobin levels in children (Bloem et al, 1989 (Bloem et al, , 1990 ).
An additional intervening factor might be related to the study group itself. Our study concerned adult non-pregnant women, whereas other supplementation studies gave vitamin A to pregnant women. In Indonesia (Suharno et al, 1993 ) the increase in haemoglobin was found to be 50% higher when vitamin A was supplied with iron and suf®-cient to eliminate anaemia in 97% of those anaemic pregnant women who received both vitamin A and iron. The needs for iron during pregnancy are, however, considerably higher. The effect of vitamin A might thus have induced higher haemoglobin changes owing to the higher demands and the need to mobilise iron stores. Iron is in particular sequestrated in liver and bone marrow in a vitamin A de®ciency state (Bloem, 1995) . Women of Dinajpur are also very thin; 44% of them have a BMI`18.5 kgam 2 and should be considered malnourished. This general degree of undernutrition might have decreased the possible response to treatment. Indeed, an increase of 1.5 gal of Hb over 2 months is well below the 20 gal increase over 3 weeks that is the normal response to treatment in iron de®ciency (Frewin et al, 1997) . It should be emphasised that in the present population 2 months of treatment only corrected anaemia in 6% of the women who received treatment.
A ®nal explanation is related to the sample size, which was calculated to demonstrate signi®cant differences with a difference of 5 gal for a standard deviation of 10 gal. In the present study the standard deviation in the group receiving all three supplements was 13 gal and the differences z, Probability of paired t-test on the difference compared to the group who received iron alone. f, Probability of paired t-test on the difference compared to the group who received iron alone.
Vitamin Aazinc supplementation and anaemia P Kolsteren et al between the groups were smaller than ®rst expected. This might explain the fact that an inter-group difference of 3 gal was not found to be signi®cantly different.
The women who received zinc as part of the treatment showed no increase in serum values. It is very probable that the women took all medication at the same time, even when requested to take it with separate meals. The most likely explanation would then be that the therapeutic dosage of iron inhibited most of the zinc uptake, as it is known that these elements compete for the absorption receptors (Fairweather-Tait et al, 1995) . In Nigeria, however, no effect of iron supplementation could be demonstrated on zinc metabolism (Arnaud et al, 1993) . The authors concluded that iron supplementation did not interfere with normal zinc absorption. On the other hand, it is also accepted that serum zinc levels do not well re¯ect the zinc status of an individual (Golden & Golden, 1981) . It is therefore dif®cult to draw conclusions on whether the population was zinc de®cient or not.
Overall the present study could not determine that a single dose of vitamin A added to iron treatment improved response to iron therapy. The addition of zinc to the treatment regimen gave better results, but these results should be interpreted carefully given the overall small response to treatment. That the response is so small underlines the importance of the possible role that other de®-ciencies might play in hampering the response to iron treatment for iron de®ciency anaemia in poor countries where malnutrition is still very prevalent.
